207 related articles for article (PubMed ID: 21744429)
1. Screening for cervical and breast cancer among women with inflammatory bowel disease: a population-based study.
Singh H; Nugent Z; Demers AA; Bernstein CN
Inflamm Bowel Dis; 2011 Aug; 17(8):1741-50. PubMed ID: 21744429
[TBL] [Abstract][Full Text] [Related]
2. Risk of cervical abnormalities in women with inflammatory bowel disease: a population-based nested case-control study.
Singh H; Demers AA; Nugent Z; Mahmud SM; Kliewer EV; Bernstein CN
Gastroenterology; 2009 Feb; 136(2):451-8. PubMed ID: 18996382
[TBL] [Abstract][Full Text] [Related]
3. Women with inflammatory bowel disease do not receive adequate cervical cancer screening or pregnancy counseling.
Greywoode R; LaFond J; Fine S; Al-Bawardy B; Jencks D; Shafa S; Borum ML
Inflamm Bowel Dis; 2013 Jan; 19(1):E6-7. PubMed ID: 22109963
[No Abstract] [Full Text] [Related]
4. Higher incidence of abnormal Pap smears in women with inflammatory bowel disease.
Kane S; Khatibi B; Reddy D
Am J Gastroenterol; 2008 Mar; 103(3):631-6. PubMed ID: 17941962
[TBL] [Abstract][Full Text] [Related]
5. Breast and cervical cancer screening disparities associated with disability severity.
Horner-Johnson W; Dobbertin K; Andresen EM; Iezzoni LI
Womens Health Issues; 2014; 24(1):e147-53. PubMed ID: 24439941
[TBL] [Abstract][Full Text] [Related]
6. Disparities in receipt of breast and cervical cancer screening for rural women age 18 to 64 with disabilities.
Horner-Johnson W; Dobbertin K; Iezzoni LI
Womens Health Issues; 2015; 25(3):246-53. PubMed ID: 25864023
[TBL] [Abstract][Full Text] [Related]
7. Predictors of breast and cervical cancer screening in a Spanish metropolitan area.
López-de-Andrés A; Martin-Lopez R; Hernández-Barrera V; Carrasco-Garrido P; Gil-de-Miguel A; Esteban y Peña MM; Jiménez-García R
J Womens Health (Larchmt); 2010 Sep; 19(9):1675-81. PubMed ID: 20799924
[TBL] [Abstract][Full Text] [Related]
8. Suboptimal rates of cervical testing among women with inflammatory bowel disease.
Long MD; Porter CQ; Sandler RS; Kappelman MD
Clin Gastroenterol Hepatol; 2009 May; 7(5):549-53. PubMed ID: 18996498
[TBL] [Abstract][Full Text] [Related]
9. Differences in Breast and Cervical Cancer Screening Rates in Jordan among Women from Different Socioeconomic Strata: Analysis of the 2012 Population-Based Household Survey.
Al Rifai R; Nakamura K
Asian Pac J Cancer Prev; 2015; 16(15):6697-704. PubMed ID: 26434897
[TBL] [Abstract][Full Text] [Related]
10. Breast and cervical cancer screening utilization among Hispanic women living near the United States-Mexico border.
Nuño T; Castle PE; Harris R; Estrada A; García F;
J Womens Health (Larchmt); 2011 May; 20(5):685-93. PubMed ID: 21428792
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing the mammography utilization among Taiwanese women with intellectual disabilities, a nationwide population-based study.
Lai HT; Kung PT; Tsai WC
Res Dev Disabil; 2014 Dec; 35(12):3372-8. PubMed ID: 25194512
[TBL] [Abstract][Full Text] [Related]
12. Barriers and missed opportunities in breast and cervical cancer screening among women aged 50 and over, New York City, 2002.
Nash D; Chan C; Horowitz D; Vlahov D
J Womens Health (Larchmt); 2007; 16(1):46-56. PubMed ID: 17324096
[TBL] [Abstract][Full Text] [Related]
13. Lack of association between cervical dysplasia and IBD: a large case-control study.
Lees CW; Critchley J; Chee N; Beez T; Gailer RE; Williams AR; Shand AG; Arnott ID; Satsangi J
Inflamm Bowel Dis; 2009 Nov; 15(11):1621-9. PubMed ID: 19618462
[TBL] [Abstract][Full Text] [Related]
14. Effects of Cardiovascular Disease on Compliance with Cervical and Breast Cancer Screening Recommendations Among Adult Women.
Guo F; Hirth JM; Berenson AB
J Womens Health (Larchmt); 2015 Aug; 24(8):641-7. PubMed ID: 26263281
[TBL] [Abstract][Full Text] [Related]
15. Effect of comorbid mood and anxiety disorders on breast and cervical cancer screening in immune-mediated inflammatory disease.
Marrie RA; Walld R; Bolton JM; Sareen J; Patten SB; Singer A; Lix LM; Hitchon CA; Marriott JJ; El-Gabalawy R; Katz A; Fisk JD; Bernstein CN;
PLoS One; 2021; 16(8):e0249809. PubMed ID: 34351924
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing the uptake of screening services for breast and cervical cancer in Taiwan.
Lin SJ
J R Soc Promot Health; 2008 Nov; 128(6):327-34. PubMed ID: 19058475
[TBL] [Abstract][Full Text] [Related]
17. Abnormal Pap smears in women with Crohn's disease: is there a role for defensin deficiency?
Savoye G; Lerebours E
Am J Gastroenterol; 2008 Apr; 103(4):1046-7; author reply 1047. PubMed ID: 18397432
[No Abstract] [Full Text] [Related]
18. Changes in the social gradients for Pap smears and mammograms in Argentina: evidence from the 2005 and 2009 National Risk Factor Surveys.
De Maio FG; Linetzky B; Ferrante D
Public Health; 2012 Oct; 126(10):821-6. PubMed ID: 23083845
[TBL] [Abstract][Full Text] [Related]
19. Breast and cervical cancer screening in obese minority women.
Ferrante JM; Chen PH; Jacobs A
J Womens Health (Larchmt); 2006 Jun; 15(5):531-41. PubMed ID: 16796480
[TBL] [Abstract][Full Text] [Related]
20. Sociodemographic gradients in breast and cervical cancer screening in Korea: the Korean National Cancer Screening Survey (KNCSS) 2005-2009.
Park MJ; Park EC; Choi KS; Jun JK; Lee HY
BMC Cancer; 2011 Jun; 11():257. PubMed ID: 21682886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
